secwatch / observer

8-K filed October 17, 2025, 7:59 PM ET ticker PHGE CIK 0001739174

other material confidence high sentiment neutral materiality 0.40

BiomX shareholders approve reverse stock split authorization and elect Class II directors

BiomX Inc.

Elected Susan Blum, Dr. Jesse Goodman, and Gregory Merril as Class II directors until 2028.
Approved board authority to reverse split common stock at a ratio between 1-for-5 and 1-for-20 (13.6M votes for, 383.7K against).
Ratified Kesselman & Kesselman (PwC member) as independent auditor for fiscal 2025 with 14.05M votes for.
Adjournment proposal not called due to sufficient votes on other proposals.
All three proposals passed; broker non-votes were zero on director elections.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-099755
form_type: 8-K
ticker: PHGE
cik: 0001739174
company_name: BiomX Inc.
filed_at: 2025-10-17T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.287503+00:00
generated_at: 2026-05-17T03:24:47.361564+00:00
sec_items: ["5.07"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-099755
json_url: https://secwatch.observer/filing/0001213900-25-099755.json
markdown_url: https://secwatch.observer/filing/0001213900-25-099755.md
text_url: https://secwatch.observer/filing/0001213900-25-099755.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/0001213900-25-099755-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/ea0261608-8k_biomx.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

SIRI

Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors

SIRIUS XM HOLDINGS INC. June 1, 2026, 4:28 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

ESPR

Esperion shareholders approve 7M-share increase to 2022 equity incentive plan

Esperion Therapeutics, Inc. June 1, 2026, 4:22 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

RDAC

Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp. June 1, 2026, 6:08 AM ET other_material Items 1.01, 5.03, 5.07, 8.01, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

TNYA

Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors

Tenaya Therapeutics, Inc. May 29, 2026, 5:04 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

SYRE

Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns

Spyre Therapeutics, Inc. May 29, 2026, 4:45 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

EVC

Entravision stockholders approve 6M share increase in equity plan at annual meeting

ENTRAVISION COMMUNICATIONS CORP May 29, 2026, 4:30 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-25-099755

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.